Cedars-Sinai Cancer has appointed three leaders to new roles.
Lali Medina-Kauwe, PhD, former co-leader of the cancer biology program, is now the associate director for basic research. Dr. Medina-Kauwe, who joined the Cedars-Sinai faculty in 2003, has a PhD in molecular biology. Her research focuses on the development of non-infective virus proteins that can deliver treatments to triple-negative breast cancer that has metastasized in the brain.
The cancer biology program will now be led by Dolores Di Vizio, MD, PhD, professor of biomedical sciences, pathology and laboratory medicine in the department of surgery, and Xue Sean Li, PhD, professor of medicine and biomedical sciences.
Dr. Di Vizio has been at Cedars-Sinai for 10 years. She earned her medical degree and a PhD in molecular and cell biology in Italy, did postdoctoral work at New York City-based Albert Einstein College of Medicine and Cambridge, Mass.-based Harvard University, where she was an instructor and assistant professor before joining the Cedars-Sinai faculty.
Dr. Li joined the Cedars-Sinai faculty two years ago. From 2003 to 2018, he worked at Boston-based Harvard Medical School and Boston Children's Hospital. His research is focused on sex differences in development and diseases.